Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs

被引:134
作者
Jo, Eun-Kyeong [1 ]
机构
[1] Chungnam Natl Univ, Dept Microbiol, Infect Signaling Network Res Ctr, Coll Med, Taejon 301747, South Korea
关键词
C-type lectins; innate immune responses; mycobacteria; NOD-like receptors; toll-like receptors;
D O I
10.1097/QCO.0b013e3282f88b5d
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review The recent discovery of novel classes of receptors, including toll-like receptors and nucleotide-binding oligomerization domain (NOD)-like receptors is challenging the crucial role of the innate immune system in the recognition of Mycobacterium tuberculosis. The present review is to focus on the roles and mechanisms of specific pattern-recognition receptor-microbial interaction for the host defense against mycobacterial infections. Recent findings Toll-like receptors, key players in innate immunity, are now known to be important for the initiation and coordination of host responses to Mycobacterium tuberculosis. The interaction of Mycobacterium tuberculosis with toll-like receptors triggers intracellular signaling cascades that culminate in a proinflammatory response, but can also trigger signals that dampen the innate immune response. Other membrane-bound pattern-recognition receptors, including the mannose receptor, DC-SIGN, and Dectin-1, contribute to the propagation of Mycobacterium tuberculosis inflammatory signals, and Nod-like receptors (cytosolic pattern-recognition receptors) also act in modulating host recognition of Mycobacterium tuberculosis. Interactions between toll-like receptors and other pattern-recognition receptors are also evident in responses to Mycobacterium tuberculosis, as are possible mechanisms for coordination of innate and adaptive immunity. Summary The complexity of Mycobacterium tuberculosis-pattern-recognition receptor interactions and their effects on host cell responses suggest key roles for innate immunity in controlling Mycobacterium tuberculosis, and the possibility of developing novel therapeutics for tuberculosis that target Mycobacterium tuberculosis-regulated innate immunity pathways.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 67 条
[1]   Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice [J].
Abel, B ;
Thieblemon, N ;
Quesniaux, VJF ;
Brown, N ;
Mpagi, J ;
Miyake, K ;
Bihl, F ;
Ryffel, B .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3155-3162
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]   Toll-like receptors: lessons from knockout mice [J].
Akira, S .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2000, 28 :551-556
[4]   TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis [J].
Bafica, A ;
Scanga, CA ;
Feng, CG ;
Leifer, C ;
Cheever, A ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1715-1724
[5]   Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis [J].
Barreiro, LB ;
Neyrolles, O ;
Babb, CL ;
Tailleux, L ;
Quach, H ;
McElreavey, K ;
van Helden, PD ;
Hoal, EG ;
Gicquel, B ;
Quintana-Murci, L .
PLOS MEDICINE, 2006, 3 (02) :230-235
[6]   Crohn's disease, mycobacteria, and NOD2 [J].
Behr, MA ;
Semret, M ;
Poon, A ;
Schurr, E .
LANCET INFECTIOUS DISEASES, 2004, 4 (03) :136-137
[7]   Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients [J].
Ben-Ali, Meriem ;
Barreiro, Luis B. ;
Chabbou, Abdellatif ;
Haltiti, Raja ;
Braham, Ezzeddine ;
Neyrolles, Olivier ;
Dellagi, Koussay ;
Gicquel, Brigitte ;
Quintana-Murci, Lluis ;
Barbouche, Mohamed-Ridha .
HUMAN IMMUNOLOGY, 2007, 68 (11) :908-912
[8]   The glycosyltransferases of Mycobacterium tuberculosis -: roles in the synthesis of arabinogalaetan, lipoarahinolrnlannan, and other glyeoeonjugates [J].
Berg, Stefan ;
Kaur, Devinder ;
Jackson, Mary ;
Brennan, Patrick J. .
GLYCOBIOLOGY, 2007, 17 (06) :35R-56R
[9]   Dectin-1 mediates the biological effects of β-glucans [J].
Brown, GD ;
Herre, J ;
Williams, DL ;
Willment, JA ;
Marshall, ASJ ;
Gordon, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1119-1124
[10]  
Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745